newsfilter
← Latest News
PR Newswire·

BiondVax CEO to Present at the January 2023 Biotech Showcase in San Francisco

JERUSALEM , Nov. 21, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) ("BiondVax"), a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic